Brian J. Gangle

Array ( [id] => 8549046 [patent_doc_number] => 08323927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Preparation of protective antigen' [patent_app_type] => utility [patent_app_number] => 13/246659 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 17640 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13246659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054097 [patent_doc_number] => 20120076780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'RECOMBINANT FUSION PROTEIN AND POLYNUCLEOTIDE CONSTRUCT FOR IMMUNOTOXIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/239847 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 27715 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076780.pdf [firstpage_image] =>[orig_patent_app_number] => 13239847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10280011 [patent_doc_number] => 20150165009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'TLR5 LIGANDS, THERAPEUTIC METHODS, AND COMPOSITIONS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 13/825349 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10683 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710221 [patent_doc_number] => 20120003223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'RECOMBINANT FUSION PROTEIN AND POLYNUCLEOTIDE CONSTRUCT FOR IMMUNOTOXIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/233718 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 22561 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13233718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802176 [patent_doc_number] => 08440450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Antibiotic-sensitive lactic acid bacteria strains' [patent_app_type] => utility [patent_app_number] => 13/233507 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21595 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13233507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662303 [patent_doc_number] => 20110311572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'NUCLEOTIDE AND AMINO ACID SEQUENCES ENCODING AN EXPORTED PROTEIN 1 DERIVED FROM PLASMODIUM VIVAX AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/219802 [patent_app_country] => US [patent_app_date] => 2011-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25107 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311572.pdf [firstpage_image] =>[orig_patent_app_number] => 13219802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10143328 [patent_doc_number] => 09176135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Method for predicting and preventing cardiovascular disease' [patent_app_type] => utility [patent_app_number] => 13/818405 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16887 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776440 [patent_doc_number] => 20120039942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'OUTER MEMBRANE VESICLES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/211977 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29178 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039942.pdf [firstpage_image] =>[orig_patent_app_number] => 13211977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305407 [patent_doc_number] => 08226937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Agents for promoting IgA production' [patent_app_type] => utility [patent_app_number] => 13/208597 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3766 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13208597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950040 [patent_doc_number] => 20130195820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'USE OF BLOOD GROUP STATUS III' [patent_app_type] => utility [patent_app_number] => 13/812799 [patent_app_country] => US [patent_app_date] => 2011-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11913 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12329595 [patent_doc_number] => 09945855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Method for linking point of care rapid diagnostic testing results to laboratory-based methods [patent_app_type] => utility [patent_app_number] => 13/810948 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 5216 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9957402 [patent_doc_number] => 09005601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Methods and compositions including spore-forming bacteria for increasing the health of animals' [patent_app_type] => utility [patent_app_number] => 13/810549 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4807 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814164 [patent_doc_number] => 20130115209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS PROTEIN SA2412' [patent_app_type] => utility [patent_app_number] => 13/810130 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10686 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413057 [patent_doc_number] => 08697093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Vaccine composition based on sticholysin encapsulated into liposomes' [patent_app_type] => utility [patent_app_number] => 13/808276 [patent_app_country] => US [patent_app_date] => 2011-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 5703 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8791685 [patent_doc_number] => 20130108654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'TELOMERASE ACTIVITY INHIBITING PEPTIDE AND MANUFACTURING METHOD AND APPLICATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/808059 [patent_app_country] => US [patent_app_date] => 2011-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9924 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891147 [patent_doc_number] => 20130164331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'ORAL VACCINATION OF FISH WITH LIVE ATTENUATED EDWARDSIELLA ICTALURI VACCINES' [patent_app_type] => utility [patent_app_number] => 13/261536 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9149 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8865637 [patent_doc_number] => 20130149339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS' [patent_app_type] => utility [patent_app_number] => 13/701467 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 22968 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8745551 [patent_doc_number] => 20130085268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'MEANS FOR THE TRANSIENT PRODUCTION IN PLANTS OF RECOMBINANT PROTEINS THAT CAN BE USED IN PARTICULAR IN PROPHYLAXIS AND IN THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 13/699014 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4086 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221245 [patent_doc_number] => 20120135453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Methods of Treatment Using CCA1 Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/116962 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7309 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932212 [patent_doc_number] => 08491908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Composite particle, contrast agent for photoacoustic imaging, and method for producing the composite particle' [patent_app_type] => utility [patent_app_number] => 13/115276 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 13862 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13115276 [rel_patent_id] =>[rel_patent_doc_number] =>)